ASCO: Erbitux May Boost CRC Survival

CHICAGO (MedPage Today) -- Survival in metastatic colorectal cancer increased significantly despite no slowing of tumor growth when one targeted agent was added to chemotherapy but not another, data from a large randomized trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/asco-erbitux-may-boost-crc-survival.html